Stable aqueous anti-vascular endothelial growth factor (VEGF) antibody formulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10894083
APP PUB NO 20180000933A1
SERIAL NO

15546370

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by an aqueous formulation of an anti-vascular endothelial growth factor (VEGF) antibody.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PFIZER INC66 HUDSON BOULEVARD EAST LEGAL PATENT DEPT CHIEF IP COUNSEL NEW YORK NY 10001-2192

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ingram, Rebecca Lee Billerica, US 2 0
Weiser, Sarah Elizabeth Waltham, US 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 19, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 19, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00